Skip to main content

Chirurgische Therapie des intrahepatischen cholangiozellulären Karzinoms

Surgical therapy of intrahepatic cholangiocellular carcinoma

Der Chirurg volume 77, pages 53–60 (2006)Cite this article

Zusammenfassung

Hintergrund

Intrahepatische cholangiozelluläre Karzinome (CCC) sind der zweithäufigste primäre epitheliale Lebertumor. Obwohl die Leberresektion die Therapie der Wahl darstellt, liegen bislang nur wenige valide Daten über den Wert dieser Therapieform vor. Wir verfolgen bei dieser Tumorentität einen aggressiven chirurgischen Therapienansatz.

Patienten und Methode

Von 04/1998 bis 06/2004 wurden bei 120 Patienten mit CCC 54 Leberresektionen durchgeführt. Zudem wurden bei 24 Patienten die folgenden 39 Operationserweiterungen vorgenommen: Hepatikusgabelresektion (n=18), Zwerchfellteilresektion (n=6), Gefäßresektion und -rekonstruktion (n=15).

Ergebnisse

Es wurden 30 R0-, 21 R1- und 3 R2-Resektionen erreicht. Nach inkompletter Resektion oder explorativer Laparotomie liegt das mediane Überleben bei 9 bzw. 6 Monaten. Demgegenüber beträgt das mediane Überleben nach R0-Resektion 46 Monate mit 1-/3-/5-Jahres-Überlebensraten von 83%/58%/48%.

Schlussfolgerung

Die Daten zeigen, dass auch beim CCC durch eine R0-Resektion eine signifikante Prognoseverbesserung erreicht werden kann. Die inkomplette Tumorentfernung führt dagegen zu nahezu keiner Verbesserung des Patientenüberlebens. Dies rechtfertigt ein aggressives chirurgisches Vorgehen bei dieser Tumorentität mit dem ausdrücklichen Ziel der RO-Resektion. Die niedrige Resektionsrate von weniger als 50% verdeutlicht die Notwendigkeit für ein verbessertes präoperatives Staging.

Abstract

Background

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy. Tumor resection is the treatment of choice, but so far the value of hepatic resection has not been well defined. We report results with an aggressive surgical approach for the treatment of this tumor entity.

Patients and methods

Between April 1998 and June 2004, 54 liver resections were performed in 120 patients with ICC. In 24 patients, 39 additional procedures were performed: resection of hilar bifurcation (n=18), partial resection of diaphragm (n=6), vascular resection and reconstruction (n=15).

Results

There were 30 R0, 21 R1, and three R2 resections. After R1/R2 resection and explorative laparotomy, the median survival times are 9 months and 6 months, respectively. Following R0 resection, the calculated median survival is 46 months, and the 1-, 3-, and 5-year survival rates are 83%, 58%, and 48%, respectively.

Conclusion

The presented data show that R0 resection leads to a significant prolongation of survival in patients with ICC. In contrast, incomplete tumor removal does not provide a survival benefit. These results justify an aggressive surgical approach to achieve a R0 resection. The low resectability rate of less than 50% underlines the need for improved preoperative staging.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Adam R, Bismuth H, Castaing D et al. (1997) Repeat hepatectomy for colorectal liver metastases. Ann Surg 225:51–60

    Article  PubMed  Google Scholar 

  2. D‘Angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP (2003) The role of staging laparoscopy in hepatobiliary malignancy:prospective analysis of 401 cases. Ann Surg Oncol 10: 183

    Article  PubMed  Google Scholar 

  3. Barbot DJ, Marks JH, Feld RI, Liu JB, Rosato FE (1997) Improving staging of liver tumors using laparoscopic intraoperative ultrasound. J Surg Oncol 64:63

    Article  PubMed  Google Scholar 

  4. Berdah SV, Delpero JR, Garcia S, Hardwigsen J, Le Treut YP (1996) A western surgical experience of peripheral cholangiocarcinoma. Br J Surg 83:1517

    PubMed  Google Scholar 

  5. Casavilla FA, Marsh JW, Iwatsuki S et al. (1997) Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 185:429

    Article  PubMed  Google Scholar 

  6. Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen CL (1997) Surgical treatment of cholangiocarcinoma. Hepatogastroenterology 44:760

    PubMed  Google Scholar 

  7. Chu KM, Lai EC, Al-Hadeedi S et al. (1997) Intrahepatic cholangiocarcinoma. World J Surg 21:301

    Article  PubMed  Google Scholar 

  8. Hanazaki K, Kajikawa S, Shimozawa N et al. (2002) Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 49:311

    PubMed  Google Scholar 

  9. Harrison LE, Fong Y, Klimstra DS, Zee SY, Blumgart LH (1998) Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 85:1068

    Article  PubMed  Google Scholar 

  10. Herfarth Ch, Heuschen UA, Lamade W, Lehnert T, Otto G (1995) Rezidivresektionen an der Leber bei primären und sekundären Lebermalignomen. Chirurg 66:949

    PubMed  Google Scholar 

  11. Inoue K, Makuuchi M, Takayama T et al. (2000) The separate-lesion type cholangiocarcinoma. Surgery 127:498

    PubMed  Google Scholar 

  12. Itamoto T, Asahara T, Katayama et al. (2001) Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology. Hepatogastroenterology 48:1129

    PubMed  Google Scholar 

  13. Jarnagin WR, Saldiner PF, Blumgart LH (2000) Cancer of the bile ducts: The hepatic ducts and common bile duct. In: Blumgart LH, Fong Y (eds) Surgery of the liver and biliary tract, 3rd edition. WB Saunders, London Edinburgh New York, S 1017

  14. Kawarada Y, Yamagiwa K, Das BC (2002) Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 183:679

    Article  PubMed  Google Scholar 

  15. Lang H, Radtke A, Liu C, Frühauf NR, Peitgen HO, Broelsch CE (2004) Extended left hepatectomy — modified operation planning based on three-dimensional (3D)-visualization of liver anatomy. Langenbeck’s Arch Surg 389:306

    Google Scholar 

  16. Lang H, Sotiropoulos GC, Dömland M et al. (2005) Extended hepatectomy for intrahepatic Cholangiocellular carcinoma (ICC) — when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-years-period. Ann Surg 241:134

    PubMed  Google Scholar 

  17. Lang H, Radtke A, Hindennach M Peitgen et al. (2005) Impact of Virtual tumor resection and computer-assisted risk analysis on operation planning and intraoperative strategy in major hepatic resection. Arch Surg 140:629

    Article  PubMed  Google Scholar 

  18. Lieser MJ, Barry MK, Rowland C, Ilstrup DM, Nagorney DM (1998) Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobil Pancreat Surg 5:41

    Google Scholar 

  19. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE (1998) Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 227:70

    Google Scholar 

  20. Meyer CG, Penn I, James L (2000) Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69:1633

    Article  PubMed  Google Scholar 

  21. Nakeeb A, Pitt HA, Sohn TA et al. (1996) Cholangiocarcinoma: a spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 224:463

    Article  Google Scholar 

  22. Ohtsuka M, Ito H, Kimura F, Shimizu, Togawa A, Yoshidome H, Miyazaki M (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing the survival. Br J Surg 89:1525

    Article  PubMed  Google Scholar 

  23. Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353

    Article  PubMed  Google Scholar 

  24. Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B (1995) Surgical treatment of cholangiocellular carcinoma. World J Surg 19:83

    Article  PubMed  Google Scholar 

  25. Roayaie S, Guarrera JV, Ye MQ et al. (1998) Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 187:365

    Article  PubMed  Google Scholar 

  26. Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K (2001) Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88:1463

    Article  PubMed  Google Scholar 

  27. Shimoda M, Farmer DG, Colquhoun SD et al. (2001) Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 7:1023

    Article  PubMed  Google Scholar 

  28. Sobin LH, Wittekind CH (2002) TNM Classification of malignant tumours. Sixth edition. John Wiley & Sons Ltd, West Sussex

  29. Sotiropoulos GC, Lang H, Broelsch CE (2005) Surgical management of recurrent intrahepatic cholangiocellular carcinoma after liver resection. Surgery 137:669

    Article  Google Scholar 

  30. Taylor-Robinson SD, Toledano M, Arora S et al. (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut 48:816

    Article  PubMed  Google Scholar 

  31. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH (2001) Intrahepatic cholangiocarcinoma: resectability, recurrence patterns, and outcomes. J Am Coll Surg 193:384

    Article  PubMed  Google Scholar 

  32. Weimann A, Varnholt H, Schlitt HJ et al. (2000) Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocarcinoma. Br J Surg 87:182

    Article  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Affiliations

  1. Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Essen

    H. Lang, G. C. Sotiropoulos, E. Brokalaki, N. R. Frühauf, J. Radü, A. Paul, M. Malagó & C. E. Broelsch

  2. Institut für Pathologie, Universitätsklinikum Essen

    J. Wohlschlaeger & H. A. Baba

  3. Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Hufelandstraße 55, 45122 , Essen

    H. Lang

Authors
  1. H. Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. C. Sotiropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Brokalaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. R. Frühauf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Radü
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Wohlschlaeger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. A. Baba
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Malagó
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. E. Broelsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Lang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lang, H., Sotiropoulos, G.C., Brokalaki, E. et al. Chirurgische Therapie des intrahepatischen cholangiozellulären Karzinoms. Chirurg 77, 53–60 (2006). https://doi.org/10.1007/s00104-005-1069-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-005-1069-z

Schlüsselwörter

  • Intrahepatisches cholangiozelluläres Karzinoms
  • Leberresektion
  • Überlebensrate
  • Tumorstaging

Keywords

  • Intrahepatic cholangiocellular carcinoma
  • Liver resection
  • Survival rates
  • Tumor staging